Intracellular delivery of anti-BCR/ABL antibody by PLGA nanoparticles suppresses the oncogenesis of chronic myeloid leukemia cells
Guoyun Jiang(Chongqing Medical University), Wenli Feng(Chongqing Medical University)
Cited by 38
Related Papers
Inhibition of YAP suppresses CML cell proliferation and enhances efficacy of imatinib in vitro and in vivo
|Journal of Experimental & Clinical Cancer Research|2016|43
Efficient disruption of bcr-abl gene by CRISPR RNA-guided FokI nucleases depresses the oncogenesis of chronic myeloid leukemia cells
|Journal of Experimental & Clinical Cancer Research|2019|39
TCF7 knockdown inhibits the imatinib resistance of chronic myeloid leukemia K562/G01 cells by neutralizing the Wnt/β‑catenin/TCF7/ABC transporter signaling axis
|Oncology Reports|2020|37